Pharmaceutical Industry

Page 12 of 100

Thomas Schinecker, CEO of Roche Holding.
Retail

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value

By Naomi Kresge, Lisa Pham and Bloomberg
July 23, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
Commentary

Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap

By Katie Britt, Terri Sewell, Kay Ivey and Randall Woodfin
July 3, 2024
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
Commentary

Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early

By
July 2, 2024
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
Health

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

By
June 28, 2024
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream 
Tech

Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream 

By
June 25, 2024
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak
Commentary

‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak

By
June 24, 2024
Paul Hudson, CEO of Sanofi.
Leadership

Forget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’

By
June 20, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
Retail

Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why

By
June 17, 2024
A factory worker packs supplements inside a box.
Health

Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it has twice the amount of recalls on store-brand drugs than competitors

By
June 11, 2024
Blonde woman walking down pharmacy aisles
Politics

Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say

By Susan Jaffe and KFF Health News
June 11, 2024
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
Health

Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers

By Matthew Perrone and The Associated Press
June 11, 2024
Female CEOs used to run America’s top drugstores. But two powerful women were replaced this year as pharmacies face a national crisis
Newsletters

Female CEOs used to run America’s top drugstores. But two powerful women were replaced this year as pharmacies face a national crisis

By Maria Aspan and Joey Abrams
June 7, 2024
Woman stocks pill bottles on shelves
Health

‘You’re the smoking cessation counselor, you’re the suicide prevention counselor’—waves of pharmacy closures nationwide take a toll

By The Associated Press, Tom Murphy and Kasturi Pananjady
June 3, 2024
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Newsletters

Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly

By Peter Vanham and Nicholas Gordon
May 29, 2024

Most Popular